Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.
A 41-year-old obese Native American woman presented with hidradenitis suppurativa (HS) after failing all available treatment options.
APA
Shi W, Schultz S, et al. (2019). Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.. BMJ case reports, 12(1). https://doi.org/10.1136/bcr-2018-226064
MLA
Shi W, et al.. "Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.." BMJ case reports, vol. 12, no. 1, 2019.
PMID
30665927
Abstract
A 41-year-old obese Native American woman presented with hidradenitis suppurativa (HS) after failing all available treatment options. Her HS was more pronounced in the axillary and groin regions (Hurley stage III) and was a major source of her pain and a barrier for home exercise and aquatic therapy. She received a botulinum toxin A injection every 3 months (four times thus far), which has significantly helped alleviate her pain and curb the progress of her HS by resolving abscesses and healing draining sinuses.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 |
MeSH Terms
Adult; Botulinum Toxins, Type A; Female; Hidradenitis Suppurativa; Humans; Indians, North American; Obesity; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- A Study on the Correlation Between Caregiver Burden, Psychological Resilience, and Quality of Life in Patients With Advanced Cancer Receiving Inpatient Palliative Care.
- TGF-α/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer.
- The depletion of serine beta-lactamase-like protein (LACTB) ameliorates metabolic dysfunction-associated steatotic liver disease by reducing ubiquitin-mediated degradation of carnitine palmitoyltransferase 2.
- Ratio-Tunable Dual-Peptide and Ultrasound-Assisted Nanoplatform for Enhancing Personalized Antitumor Immunotherapy.
- CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancer.
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.